News | Sudden Cardiac Arrest | September 13, 2021

TOMAHAWK Trial Does Not Support Early Coronary Angiography in Cardiac Arrest Without ST-elevation

Late-breaking trial suggests patients without a significant coronary lesion as the trigger for cardiac arrest do not benefit from an invasive approach and might even be harmed

Siemens Artis Q angiography system #ESC #ESCcongress

September 13, 2021 — Early coronary angiography in out-of-hospital cardiac arrest (OHCA) patients without ST-segment elevation on ECG is not superior to a delayed, selective approach, according to late breaking TOMAHAWK trial presented at the European Society of Cardiology (ESC) Congress 2021.[1]

The usefulness and timing of coronary angiography in OHCA survivors without ST-segment elevation are uncertain. In up to one-third of these patients, acute myocardial infarction is the cause of cardiac arrest,[2] suggesting that diagnostic coronary angiography and potential percutaneous coronary intervention could be beneficial. 

ESC guidelines recommend considering delayed, as opposed to immediate, angiography among hemodynamically stable patients without ST-segment elevation successfully resuscitated after OHCA.[3] This was based on the randomized COACT trial, which found that an unselected immediate invasive strategy was not superior to a delayed invasive strategy.[4] The guidelines stated that ongoing trials such as TOMAHAWK would further define the possible benefit of an early invasive approach.

“TOMAHAWK was the second and largest randomized trial addressing the question of early coronary angiography in OHCA patients without ST-segment elevation. Like the COACT trial we found that early angiography was not superior to a delayed/selective approach. COACT was restricted to patients with shockable rhythm and TOMAHAWK extends the findings to patients with non-shockable rhythm," explained principal investigator Professor Steffen Desch, M.D., clinical director, the Heart Centre Leipzig, Germany.

“In TOMAHAWK, the higher rate of death or severe neurological deficit in the immediate angiography group is only hypothesis-generating. However, the results of the trial suggest that patients without a significant coronary lesion as the trigger of cardiac arrest do not benefit from an invasive approach and might even be harmed,” he said.

The randomized, open-label TOMAHAWK trial examined whether immediate coronary angiography for treating or ruling out acute coronary events in OHCA survivors without ST-segment elevation is beneficial for all-cause mortality at 30 days, compared with initial intensive care unit (ICU) assessment and delayed/selective angiography.

The trial enrolled patients age 30 years or older with successful resuscitation after OHCA, possible cardiac cause of arrest and absence of ST-segment elevation on post-resuscitation ECG. Patients with shockable and non-shockable rhythms were included.

A total of 554 patients were randomized at hospital admission in a 1:1 fashion to immediate coronary angiography or initial ICU assessment with delayed angiography if indicated. Intensive care treatment was administered according to guidelines on post-resuscitation care[5] and the decision to perform angiography or not was left to the discretion of treating physicians in the delayed/selective group. The primary endpoint was all-cause mortality at 30 days.

The primary endpoint occurred in 143 patients (54.0%) assigned to immediate coronary angiography and 122 patients (46.0%) in the delayed/selective angiography group (hazard ratio 1.28; 95% confidence interval [CI] 1.00–1.63; log-rank p=0.058). No differences in the primary endpoint were observed in pre-specified subgroups, including those with shockable versus non-shockable rhythm.

The composite secondary endpoint of all-cause death or severe neurological deficit at 30 days occurred more frequently in the immediate angiography group (relative risk 1.16; 95% CI 1.002–1.34). Other secondary endpoints such as length of ICU stay, peak troponin release, myocardial infarction or rehospitalization for congestive heart failure did not differ between groups. There were no differences between groups in safety endpoints including moderate or severe bleeding, stroke and acute renal failure requiring renal replacement therapy.

The study was supported by the DZHK (German Centre for Cardiovascular Research).

Find more ESC Hot Line late-breaking study news

 

References:

1. Steffen Desch, Anne Freund, Ibrahim Akin, et al. Angiography after Out-of-Hospital Cardiac Arrest without ST-Segment Elevation. TOMAHAWK: immediate angiography after out-of-hospital cardiac arrest. New England Journal of Medicine. August 29, 2021. DOI: 10.1056/NEJMoa2101909.

2. Zanuttini D, Armellini I, Nucifora G, et al. Predictive value of electrocardiogram in diagnosing acute coronary artery lesions among patients with out-of-hospital-cardiac-arrest. Resuscitation. 2013;84:1250–1254.

3. Collet JP, Thiele H, Barbato E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42:1289–1367.

4. Lemkes JS, Janssens GN, van der Hoeven NW, et al. Coronary angiography after cardiac arrest without ST-segment elevation. N Engl J Med. 2019;380:1397–1407.

5. Nolan JP, Soar J, Cariou A, et al. European Resuscitation Council and European Society of Intensive Care Medicine 2015 guidelines for post-resuscitation care. Intensive Care Med. 2015;41:2039–2056.
 

Related Content

A reconstructed vessel segment from a cone-beam CT created table side in the cath lab with the Philips Azurion SmartCT software.

A reconstructed vessel segment from a cone-beam CT created table side in the cath lab with the Philips Azurion SmartCT software. 

News | Angiography | April 07, 2021
April 7, 2021 — Philips Healthcare announced U.S.
More complex, longer interventional procedures such as structural heart interventions or this revascularization of a coronary chronic total occlusion (CTO) at Henry Ford Hospital in Detroit, requires angiography imaging systems that have improved image detail and lower radiation dose. However, purchase of new systems was put on hold by many hospitals in 2020 due to the sudden drop in elective procedures and diversion of resources due to the COVID-19. Photo by Dave Fornell. Interventional X-ray market.

More complex, longer interventional procedures such as structural heart interventions or this revascularization of a coronary chronic total occlusion (CTO) at Henry Ford Hospital in Detroit, requires angiography imaging systems that have improved image detail and lower radiation dose. However, purchase of new systems was put on hold by many hospitals in 2020 due to the sudden drop in elective procedures and diversion of resources due to the COVID-19. Photo by Dave Fornell.

Feature | Angiography | January 19, 2021 | By Bhvita Jani
January 19, 2021 – With the postponement of non-essential elective surgeries and medical procedures in 2020 to conser
GE Healthcare is introducing a new, smaller and lighter weight robotic driven angiography system for image guided therapy, the Allia IGS 7 angiography system. #RSNA20 #RSNA2020

The GE Healthcare Allia IGS 7 angiography system.

News | Angiography | December 01, 2020
December 3, 2020 — GE Healthcare is introducing a new version of its robotic driven ...
Philips Healthcare's new Fiber Optic RealShape (FORS) technology creates real-time 3-D imaging of anatomy and devices inside the body using light, rather than X-rays. FORS uses light traveling through hair-thin fiber optics inside special FORS enabled catheter and guidewires.

Philips Healthcare's new Fiber Optic RealShape (FORS) technology creates real-time 3-D imaging of anatomy and devices inside the body using light, rather than X-rays. FORS uses light traveling through hair-thin fiber optics inside special FORS enabled catheter and guidewires. 

Feature | Angiography | March 12, 2020 | Dave Fornell, Editor
Philips is working on a prototype cath lab angiographic imaging system that might be able to replace the current X-ra
he University of Wisconsin (UW) Health’s University Hospital in Madison, Wis., recently became the first facility in the United States to install the Artis icono biplane angiography imaging system from Siemens Healthineers.
News | Angiography | February 12, 2020
February 12, 2020 — The University of Wisconsin (UW) Health’s University Hospital in Madison, Wis., recently became t
Canon Medical Launches Alphenix Encore Plus Program
News | Angiography | October 09, 2019
In the complex and fast-paced world of healthcare, customers face the challenge of staying up-to-date with the most...
The Artis icono biplane angiography system is designed for use in neurointerventions and interventional radiology

The Artis icono biplane angiography system is designed for use in neurointerventions and interventional radiology. Image courtesy of Siemens Healthineers.

Technology | Angiography | September 17, 2019
The U.S. Food and Drug Administration (FDA) has cleared the Artis icono, a high-precision family of angiography systems...
Jackson Memorial Hospital Holds Ribbon-cutting for New Cardiac Catheterization Labs
News | Angiography | August 21, 2019
Jackson Memorial Hospital in Miami celebrated the opening of two newly renovated cardiac catheterization suites during...
Mentice and Siemens Healthineers Integrate VIST Virtual Patient With Artis Icono Angiography System
Technology | Angiography | June 24, 2019
Siemens Healthineers and Mentice AB announced the collaboration to fully integrate Mentice’s VIST Virtual Patient into...
Medis QAngio XA 3D Receives FDA 510k Clearance
Technology | Angiography | June 04, 2019
Medis Medical Imaging Systems B.V. has received clearance from the U.S. Food and Drug Administration for its QAangio XA...